Prev Arrow Stocks

Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 19.7% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Hims & Hers Health Inc.?

Hims & Hers Health (NYSE: HIMS) operates in the personalized health and wellness sector, witnessing a notable bearish trend in today's market.

Why is Hims & Hers Health Inc. going down?

HIMS stock is down 19.7% on Feb 21, 2025 17:06

  • The recent acquisitions of a California-based peptide facility and an at-home lab testing facility by Hims & Hers Health could be linked to the bearish turn, possibly due to concerns around integration challenges and increased expenses.
  • Market whales’ bearish positioning on HIMS options might have swayed investor sentiment, contributing to the stock's decline.
  • Despite the company's efforts to expand its offerings, industry-wide macro challenges may have dampened the positive developments, driving the bearish sentiment.
  • An undisclosed downgrade by a prominent Wall Street analyst could also have impacted investor confidence in Hims & Hers Health.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

What's Going On With Hims & Hers Health Stock Today? - Hims & Hers Health ( NYSE:HIMS )

Hims & Hers acquired a California-based peptide facility to strengthen its supply chain, improve quality control, and expand personalized tr The FDA announced the semaglutide shortage was resolved. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and ...

https://www.benzinga.com/25/02/43885942/hims-hers-acquires-peptide-facility-to-boost-innovation-and-drug-supply

0 News Article Image What's Going On With Hims & Hers Health Stock Today? - Hims & Hers Health  ( NYSE:HIMS )

Market Whales and Their Recent Bets on HIMS Options - Hims & Hers Health ( NYSE:HIMS )

Investors with a lot of money to spend have taken a bearish stance on Hims & Hers Health HIMS. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

https://www.benzinga.com/insights/options/25/02/43856424/market-whales-and-their-recent-bets-on-hims-options

1 News Article Image Market Whales and Their Recent Bets on HIMS Options - Hims & Hers Health  ( NYSE:HIMS )

Hims & Hers Health Stock Hits All-Time Highs: What's Going On? - Hims & Hers Health ( NYSE:HIMS )

Hims & Hers Health announces it acquired at-home lab testing facility Sigmund NJ LLC, marketed as Trybe Labs. The company plans to offer at-home testing capabilities through the Hims & Hers Health Platform. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, ...

https://www.benzinga.com/trading-ideas/movers/25/02/43820036/hims-hers-health-stock-hits-all-time-highs-whats-going-on

2 News Article Image Hims & Hers Health Stock Hits All-Time Highs: What's Going On? - Hims & Hers Health  ( NYSE:HIMS )

Hims & Hers Stock Jumps 156.9% in Three Months: What's Next?

HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges are likely to hurt its performance.

https://www.zacks.com/stock/news/2417456/hims-hers-stock-jumps-1569-in-three-months-whats-next

3 Missing News Article Image Hims & Hers Stock Jumps 156.9% in Three Months: What's Next?

This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Hims & Hers Health ( NYSE:HIMS ) , Datadog ( NASDAQ:DDOG )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Morgan Stanley analyst Craig Hettenbach downgraded the rating for Hims & Hers Health, Inc.

https://www.benzinga.com/25/02/43781328/this-moderna-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

4 News Article Image This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Hims & Hers Health  ( NYSE:HIMS ) , Datadog  ( NASDAQ:DDOG )

Hims & Hers Health Inc. Price History

30.00.2025 - HIMS Stock was up 5.7%

  • Despite a slip in the overall market, HIMS managed to increase by +1.01%.
  • The bearish options market dynamics on HIMS, with 50% of traders showing bearish tendencies, could have initially indicated a potential downward pressure on the stock.
  • However, the bullish movement of HIMS today suggests that positive company-specific factors or developments might have outweighed the bearish sentiment in the options market, leading to the stock's upward trajectory.
  • Investors might be optimistic about HIMS's growth prospects, possibly driven by new product launches, strategic partnerships, or strong financial performance, contributing to the stock's bullish movement despite the broader market slip.

22.00.2025 - HIMS Stock was up 5.4%

  • Unusual options activity detected for Hims & Hers Health, with a notably bullish stance from investors.
  • 60% of investors opened trades with a bullish outlook, indicating a positive sentiment towards the stock.
  • The increased bullish options activity could suggest growing confidence in the company's future performance, potentially driving the bullish movement in the stock price today.

30.00.2025 - HIMS Stock was up 7.5%

  • Today's strong bullish movement in HIMS stock can be attributed to strategic efforts by the company to improve its offerings and expand in the health and wellness sector. Despite some bearish sentiment in the options market and potential macro challenges, investors appear positive about HIMS' future prospects, leading to an increase in the stock price.

06.01.2025 - HIMS Stock was down 6.2%

  • Despite outperforming market expectations previously, the stock displayed a significant bearish trend.
  • Unusual options activity, particularly from investors holding considerable capital, appeared to indicate a bearish outlook and may have influenced the stock's decline.
  • The reasons behind the bearish options activity were unclear, potentially contributing to negative market sentiment towards Hims & Hers Health, Inc.
  • Investor reactions to anticipated future developments or news that could impact the company's performance likely played a role in driving the stock price down.

03.01.2025 - HIMS Stock was up 7.9%

  • Over the previous three months, HIMS stock rose by 69.2%, reflecting positive market sentiment despite potential challenges.
  • Despite some notable bearish positions taken by large financial institutions and high-net-worth individuals, the stock continued its upward momentum, pointing towards strong investor interest.
  • With a resilient increase of +1.01% compared to the previous day, HIMS stock displayed strength amidst a market decline.
  • Investors have shown favorability towards the company's product enhancements and wider range of offerings, reinforcing the stock's bullish trend.

24.00.2025 - HIMS Stock was up 9.1%

  • The bullish movement in HIMS stock today could be attributed to the unusual options activity detected, with a significant number of investors taking a bullish stance on the company.
  • The slight decline in the stock price mentioned previously may have been overshadowed by the overall bullish sentiment and buying pressure from investors.
  • The market's positive response to HIMS could indicate growing confidence in the company's telehealth services and potential for future growth, driving the stock price higher.

21.01.2025 - HIMS Stock was down 19.7%

  • The recent acquisitions of a California-based peptide facility and an at-home lab testing facility by Hims & Hers Health could be linked to the bearish turn, possibly due to concerns around integration challenges and increased expenses.
  • Market whales’ bearish positioning on HIMS options might have swayed investor sentiment, contributing to the stock's decline.
  • Despite the company's efforts to expand its offerings, industry-wide macro challenges may have dampened the positive developments, driving the bearish sentiment.
  • An undisclosed downgrade by a prominent Wall Street analyst could also have impacted investor confidence in Hims & Hers Health.

20.01.2025 - HIMS Stock was down 8.3%

  • Despite recent enhancements and expansions in its offerings, HIMS experienced a bearish market movement possibly due to:
  • Market whales taking a bearish stance on HIMS options, as indicated by publicly available options history.
  • Downgrade by a top Wall Street analyst, impacting investor sentiment.
  • Macro challenges that are expected to affect the company's performance.
  • The overall market trend may have also influenced the stock's movement, despite HIMS ascending while the market fell in the recent trading session.

07.01.2025 - HIMS Stock was up 6.8%

  • Despite unusual bearish options activity, HIMS stock outperformed the market, rising by 0.84%.
  • The conflicting signals from bearish options and the stock's positive performance may suggest differing investor sentiments at play.
  • The bullish movement could be a result of positive internal developments within the company, outweighing the bearish positions taken by some investors.
  • Monitoring future developments is advised to assess how these mixed signals may impact HIMS stock's performance going forward.

10.01.2025 - HIMS Stock was up 5.5%

  • Observations of unusual options activity suggested a bearish sentiment from major financial players and high-capital investors towards Hims & Hers Health (HIMS), potentially indicating a downward trend.
  • Despite the bearish stance in the options market, HIMS stock outperformed expectations, gaining +0.84% from its previous close, showcasing strength and the possibility of favorable developments within the company.
  • The unexpected uptick in HIMS stock value could be linked to positive developments, potential partnerships, or robust financial performance that counterbalanced the bearish options activity, propelling the stock on an upward trajectory.
  • Investors may have reassessed their positions based on the actual market performance of Hims & Hers Health, resulting in a shift in sentiment and driving up the stock price even in the face of initial bearish indications from the options market.

19.01.2025 - HIMS Stock was up 22.5%

  • Hims & Hers Health stock surged as the company announced the acquisition of at-home lab testing facility Sigmund NJ LLC, enhancing its offerings and expanding its health and wellness products and services.
  • Despite macro challenges that could potentially impact its performance, the company's strategic moves seem to have resonated positively with investors.
  • The downgrade by a prominent analyst did not seem to deter the bullish momentum, indicating that market sentiment was largely driven by the company's recent growth initiatives.
  • Overall, HIMS stock's bullish movement today can be attributed to the positive market reception of its expansion plans and acquisitions in the health and wellness space.

19.01.2025 - HIMS Stock was up 8.5%

  • HIMS stock jumped 156.9% in the last three months, showcasing its efforts to enhance offerings and expand its product line in the health and wellness sector.
  • Despite macro challenges, such as market volatility, HIMS managed to solidify its footing and attract investors' attention.
  • The downgrade by an analyst did not seem to deter investors, as HIMS continued its upward trajectory, closing the day with a 1.88% increase.
  • The overall positive sentiment towards HIMS indicates that investors are optimistic about the company's growth potential and ability to navigate through market uncertainties.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.